Dr. Raj Kamal Rolston

RAJ KAMAL ROLSTON, MD
Anatomic Pathology, Clinical Pathology


100 North Academy Avenue
Danville, PA 17822-0131
1 800 695 6491

Dr. Rolston is an Associate of Geisinger Medical Laboratories at Geisinger Medical Center in Danville where she focuses on clinical pathology, with a primary focus in blood bank, apheresis, immunology and molecular/genetics.

Education:

She received her MBBS from the Christian Medical College & Hospital in Vellore, India, and MD from the Departments of Biochemistry and Medicine in the same center. She was a Wellcome fellow in the Department of Medicine (Endocrinology) of the Royal Postgraduate Medical School and Hammersmith Hospital in London, England, where she worked on gut regulatory peptides.

She competed residency training at the Department of Pathology and Laboratory Medicine of MCP-Hahnemann University Hospitals in Philadelphia, Pennsylvania, and additional fellowship training in the Divisions of Molecular Diagnostics/ Molecular Pathology and Cytopathology at the University of Pittsburgh Medical Center and the Department of Surgical Pathology at the Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio.

Certifications:

Dr. Rolston is board certified in anatomic and clinical pathology. Her areas of specialization include blood banking, immunopathology, and molecular/genetics.

Professional Affiliations:

Association for Molecular Pathology (AMP)
American Association of Blood Banks (AABB)
Association of Clinical Biochemists of India (ACBI)
Endocrine Society of India (ESI)

Research Interests:

Her research interests include Alzheimer disease and aging.

Publications in Peer-Reviewed Journals:

Stone JG, Rolston RK, Ueda M, Lee HG, Richardson SL, Castellani RJ, PerryG., Smith, MA. Evidence for the Novel Expression of Human Kallikrein-related Peptidase 3, Prostate-Specific Antigen, in the Brain. Int J Clin Exp Pathol 2. 267-274, 2009.

Rolston RK. Complementary and alternative medicine (CAM) encompasses a wide variety of approaches to health and disease. Disease-A-Month 55. 119-120, 2009.

Friedlich AL, Rolston R K, Zhu X, Marlatte MW, Castellani RJ, Nunomura A, Lee H, Casadesus G , Perry G and Smith MA. Treatment advances in Alzheimer’s disease based on the oxidative stress model. Faculty 1000 Medicine Reports 1. 54-58, 2009.

Smith MA, Rolston RK. Foodborne and microbial toxins, part I: Chemical contamination and additives. Foreword. Dis Mon 55(5). 261-262, 2009.

Castellani RJ, Nunomura A, Rolston RK, Moreira PI, Takeda A, Perry G, Smith MA. Sublethal RNA oxidation as a mechanism for neurodegenerative disease. Int J Mol Sci 9. 789-806, 2008.

Liu G, Men P, Harris PL, Rolston R, Perry G, Smith MA. Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neuroscience Letters 406 (2006): 406 (3):189-193.

Liu Q, Xie F, Rolston R, Moreira PI, Nonomura A, Zhu X, Smith MA, Perry G. Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Reviews in Medical Chemistry (2007) 7(2): 171-180.

Rolston RK, Casadesus G, Webber KA, Atwood CS, Bowen RL, Perry G, Smith MA. Menopause, Estrogen and Gonadotropins in Alzheimer Disease. Advances in Clinical Chemistry (2008) 45: 139-153,

Textbook Chapters

Rolston R, Oury TD. Other Neoplasia, Chapter 8, in Pathology of Asbestos-Associated Diseases, 2nd Edition, (Roggli VL, Sporn T, Oury TD, Editors) Springer-Verlag, March 2004.

Rolston RK, Lee HG, Castellani RJ, Bajic V, Perry G, Zhu X, Smith MA. . Cell cycle related mechanisms in Alzheimer disease.. In Cell Cycle Regulators in Alzheimer’s Disease. Padmanabhan, J, eds. Research Signpost, Kerala, India, 2009, .

Lee, PL, Rolston, RK, Zhu, X, Marlatt, MW, Castellani RJ, Nunomura A, Lee, H-g, Casadesus, G, Perry, G, Smith MA. Targeting Oxidative Mechanisms in Alzheimer Disease. In Emerging Drugs and Targets for Alzheimer’s Disease. Martinez, A and Thurston, D E, eds. Royal Society of Chemistry, Cambridge, UK, 2010, 97-107.